Key points are not available for this paper at this time.
These findings unveil a critical involvement of the SGLT2/SIRT6 pathway in the inflammatory process of diabetic atherosclerotic lesions and suggest its possible favorable modulation by SGLT2i.
D’Onofrio et al. (2021) studied this question.